Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:51 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Nantahala Capital Management, LLC | 107,663 9.900% | 107,663 (New Position) | Filing History |
| 2024-02-14 4:29 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 43,568 9.676% | 12,315 (+39.41%) | Filing History |
| 2024-02-14 3:23 pm Purchase | 2023-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 109,339 9.990% | 46,504 (+74.01%) | Filing History |
| 2024-02-07 6:58 pm Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 88,744 8.700% | 24,903 (+39.01%) | Filing History |
| 2024-01-31 08:00 am Purchase | 2024-01-23 | 13G | Cellectar Biosciences, Inc. CLRB | ADAR1 Partners LP | 60,802 6.210% | 60,802 (New Position) | Filing History |
| 2023-12-07 5:15 pm Purchase | 2023-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 62,836 9.990% | 62,836 (New Position) | Filing History |
| 2023-12-05 06:01 am Purchase | 2023-11-07 | 13G | Cellectar Biosciences, Inc. CLRB | Orin Hirschman | 63,841 9.900% | 63,841 (New Position) | Filing History |
| 2023-02-13 5:53 pm Unchanged | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 71,942 9.970% | 0 (Unchanged) | Filing History |
| 2023-02-13 3:14 pm Purchase | 2022-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 16,081 4.990% | 2,155 (+15.47%) | Filing History |
| 2022-11-02 8:03 pm Purchase | 2022-10-25 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 71,942 9.970% | 51,768 (+256.60%) | Filing History |
| 2022-10-25 06:01 am Purchase | 2022-10-21 | 13G | Cellectar Biosciences, Inc. CLRB | Lincoln Park Capital Fund LLC | 31,253 9.990% | 23,541 (+305.24%) | Filing History |
| 2022-02-14 7:44 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 13,926 6.600% | -1,887 (-11.94%) | Filing History |
| 2022-02-14 1:58 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Consonance Capital Management LP | 0 0.000% | -15,678 (Position Closed) | Filing History |
| 2022-02-10 4:02 pm Sale | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Sio Capital Management LLC | 0 0.000% | -7,770 (Position Closed) | Filing History |
| 2022-01-21 3:49 pm Purchase | 2021-12-31 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 20,174 9.970% | 9,484 (+88.71%) | Filing History |
| 2021-07-08 1:30 pm Purchase | 2021-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | Rosalind Advisors Inc. | 10,691 6.000% | 10,691 (New Position) | Filing History |